TL;DR
This study identifies JFK as a hypoxia-inducible gene that promotes breast cancer initiation and progression. By uncovering the HIF-1α-JFK axis, the research reveals a novel mechanism by which breast cancer cells survive and thrive under low-oxygen conditions, suggesting JFK as a potential therapeutic target.
What Problem Does This Paper Address?
Breast cancer remains a leading cause of cancer death, and a significant challenge in its treatment is the development of resistance to radiotherapy and chemotherapy. Tumor hypoxia, a state of low oxygen within the tumor microenvironment, is strongly linked to increased malignancy, poor prognosis, and this treatment resistance. While hypoxia is known to alter cellular transcriptional profiles to promote tumor survival, the specific molecular mechanisms by which cancer cells adapt to and exploit hypoxic conditions are not fully understood. This paper aims to elucidate how breast cancer cells respond to hypoxia and how this response contributes to tumor development and treatment resistance, focusing on the role of the F-box protein JFK.
Methods
The researchers employed a multi-pronged approach to investigate the role of JFK in breast cancer under hypoxic conditions:
- In vivo studies: They utilized a MMTV-PyMT mouse model, a standard preclinical model for spontaneous breast cancer. They generated JFK transgenic (JFKTG) mice and crossed them with MMTV-PyMT mice to create JFKTG/PyMTTG mice. These mice were compared to wild-type littermates (JFKWT/PyMTTG) to assess tumor initiation, growth, and metastasis. Integrin αvβ3-targeting radiotracer SPECT/CT imaging was used to visualize tumor accumulation. Histological analysis (H&E staining) and immunohistochemistry for proliferation markers (Ki-67, PCNA) and protein expression (JFK, p53, ING4) were performed on tumor tissues.
- Cellular and molecular techniques:
- Cell Culture and Transfection: Human breast cancer cell lines (MCF-7 and T47D) were cultured under normoxic and hypoxic conditions. Transfection with expression plasmids and siRNA oligonucleotides was used to manipulate gene expression (HIF-1α and JFK).
- Western Blotting: Used to detect protein levels of JFK, HIF-1α, p53, ING4, Ki-67, PCNA, and Tubulin.
- Real-Time Reverse Transcription PCR (qPCR): Employed to measure mRNA levels of JFK and GAPDH.
- Chromatin Immunoprecipitation (ChIP) and quantitative ChIP (qChIP): Used to investigate the binding of HIF-1α to the JFK promoter.
- Luciferase Reporter Assay: To confirm the transcriptional activation of the JFK promoter by HIF-1α.
- Glucose Uptake and Lactate Production Assays: Colorimetric assays were used to measure cellular glucose uptake and lactate production, key indicators of glycolysis.
- Cell Viability Assays: Cell Counting Kit (CCK) and other assays were used to assess cell survival under various conditions, including hypoxia and treatment with ionizing radiation, tamoxifen, or fulvestrant.
- Bioinformatics and Data Analysis: Publicly available breast cancer datasets were analyzed to assess the correlation between HIF-1α and JFK mRNA expression.
Datasets
- Publicly available breast cancer datasets: The study analyzed data from GSE31192, GSE32646, and GSE21653 to evaluate the correlation between HIF-1α and JFK mRNA expression in human breast cancers.
- ChIP-seq data: Genome-wide transcriptional profile data of HIF-1α (GSE59935) was analyzed to identify candidate transcriptional targets.
Key Insights and Ideas
- JFK is a hypoxia-inducible gene: The study demonstrates that JFK expression is significantly upregulated under hypoxic conditions in breast cancer cells.
- HIF-1α directly activates JFK transcription: Hypoxia-inducible factor 1-alpha (HIF-1α) binds to the JFK promoter and drives its transcription, establishing a direct regulatory link.
- The HIF-1α-JFK axis promotes breast cancer progression: Overexpression of JFK in a mouse model accelerated tumor initiation and metastasis, suggesting its critical role in driving cancer development.
- JFK enhances hypoxia-induced glycolysis: JFK plays a crucial role in boosting glycolysis under hypoxic conditions, providing cancer cells with the energy and building blocks needed for survival and proliferation in a low-oxygen environment.
- JFK deficiency sensitizes hypoxic cells to treatment: Knocking down JFK in hypoxic breast cancer cells made them more susceptible to ionizing radiation and chemotherapy, highlighting JFK's role in treatment resistance.
- Clinical relevance of the HIF-1α-JFK axis: Analysis of patient data and tumor samples confirmed a positive correlation between HIF-1α and JFK expression in breast cancer, underscoring the clinical significance of this pathway.
Key Results
- JFKTG/PyMTTG mice developed palpable tumors earlier (12 weeks vs. 14 weeks) and had significantly larger subcutaneous tumors and a greater number of liver metastases compared to JFKWT/PyMTTG mice.
- JFKTG/PyMTTG mice showed a 3-fold increase in abnormal mitoses and significantly higher levels of Ki-67 and PCNA in tumor tissues, indicating enhanced cell proliferation.
- MCF-7 and T47D cells treated with HIF-1α siRNAs showed significantly reduced JFK expression under hypoxia.
- JFK knockdown significantly dampened hypoxia-induced glycolysis (glucose uptake and lactate production) in MCF-7 cells.
- JFK deficiency significantly weakened the increased cell viability of MCF-7 cells in response to hypoxia and treatment with ionizing radiation, tamoxifen, or fulvestrant.
- Western blotting analysis of resected breast carcinomas showed significantly upregulated HIF-1α and JFK protein levels compared to adjacent normal tissues.
- A strong positive correlation (Spearman's rank correlation coefficient of 0.690, p < 0.001) was found between JFK and HIF-1α protein levels in patient samples.
- Analysis of public datasets revealed a positive correlation between HIF-1α and JFK mRNA expression in breast cancers.
Limitations and Future Work
- HIF-2α involvement: The study acknowledges that HIF-2α, another hypoxia-inducible factor, might also bind to the JFK promoter and suggests further investigation into whether JFK is a co-target of both HIF-1α and HIF-2α under different hypoxic severities or tumor stages.
- Basal-like breast cancer: The authors propose further investigation into whether JFK levels could be useful for identifying basal-like breast cancers, which are more aggressive and associated with worse outcomes.
- Obesity and JFK: While the study notes a link between obesity and breast cancer, and a previous study showing JFK's role in hepatic lipid metabolism, the direct mechanistic link between obesity, JFK, and breast carcinogenesis requires further exploration.
- Interaction partners and degradation substrates: The authors suggest further research to characterize JFK's interaction partners and degradation substrates under various conditions (hypoxia, dysregulated energy metabolism, lipid abnormalities) to fully understand its diverse cellular functions.
- Therapeutic interventions: While JFK is proposed as a therapeutic target, further research is needed to develop specific interventions targeting the HIF-1α-JFK axis for breast cancer treatment.
Summary updated